 Correlation bromodeoxyuridine-labeling indices patient prognosis cerebral astrocytic tumors adults Bromodeoxyuridine BUdR nonradioactive thymidine analogue cells S-phase ratio BUdR-positive nuclei total number cells index LI study BUdR LI clinical course cerebral astrocytic tumors adults obtained LI broad range mean LI glioblastomas anaplastic astrocytomas astrocytomas differences significant analysis LI recurrence-free period RFP histologic findings patients LI median RFP months median RFP patients LI months Nine patients LI median follow-up months differences significant generalized Wilcoxon test proliferative potential BUdR LI good clinical indicator rate tumor growth cerebral astrocytic tumors combination histologic diagnosis BUdR LI patient prognosis